James E. Finch's Articles

  • China’s Energy Plan to Reduce Its Dependence upon Coal
    China's air pollution and coal mining deaths have horrified the global community. The country is now taking actions to reduce both. One energy plan includes coal bed methane gas, which vents the coal mines and prevents explosions. It is used as a natural gas, and is helping China expand its dependence upon a cleaner burning fuel. Now Canadian companies are rushing to China to capitalize upon the opportunities the Chinese govt is giving them. How can investors benefit from this?
  • Stimulating the Body’s Defenses to Fight Ovarian Cancer
    OvaRex® MAb is a monoclonal antibody – a biotech drug – designed to help the patient’s immune system recognize and more effectively fight ovarian cancer. OvaRex® MAb is given during the ‘watchful waiting’ period, following successful front-line therapy. It may become recognized as the most significant advance in ovarian cancer treatment since the use of chemotherapy to treat this illness.
  • Why Does a Company’s Uranium Resource Calculations Double?
    Changes in uranium mining methods, and changes in subsequent methods for calculating resources estimates, have led to companies increasing the number of pounds of uranium. This has led to some dramatic spikes in share prices for those uranium companies.
  • Exposed: The World’s Best Kept Uranium Secret
    The Republic of Niger is the world's fourth largest uranium producer, nearly monopolized by Cogema. Two newcomers recently obtain concessions to explore for uranium in properties adjacent to Cogema. Will they become a serious uranium producer in Niger?
  • James Lovelock’s Latest Book Trashes Renewables, Endorses Nuclear Energy
    James Finch reviews the latest book by James Lovelock, globally recognized as a Giant of the Environmental movement. Lovelock dissects renewable energy sources as more dangerous than advertised, more science fiction than reality. Lovelock endorses nuclear energy as the sole and safe present means of meeting global energy demands.
  • Inventor of Swiss Medica's O24 Pain Neutralizer Shares His Secrets
    Will consumers favor a non-burning pain relief product, like Swiss Medica’s (OTC BB: SWME) O24 instead of Icy Hot or Ben Gay? Richard Weise, inventor of the patented O24 pain relief product talked to us about how O24 came about, how it works differently than other pain relief products and why O24 might just become a success story during its North American rollout to retail stores.
  • The Grand Daddy Boom in Uranium
    Approaching his 50th year in the uranium business, the quiet but assertive Chairman and Chief Executive of Uranium Resources (OTC BB: URIX). Paul K. Willmott talked to us about the current uranium bull market. Willmott discussed the third uranium bull market he’s experienced with both exuberance and caution.
  • A 'Call' On The Price of Uranium?
    Uranium stocks are moving higher because of the rapid rise in the spot price of uranium. We talked to Strathmore Minerals Chief Executive Dev Randhawa about how his company may be thought of as an unexpired call option on the uranium. Because it is next to impossible to directly purchase uranium and benefit from that commodity's rising price, many investors are turning to the junior uranium development companies, such as Strathmore Minerals.
  • Canadian Coalbed Methane Stocks: 7 Things to Know Before Investing
    One of Canada's leading petrogeologists, Dr. David Marchioni, cautions investors on what they should be looking for, before investing in the red-hot Canadian Coalbed Methane (CBM) Stocks. There are 7 Key Ingredients that make up a successful CBM play. He warns that some Canadian CBM plays are pricey and mature, although many investors are still climbing onboard the bandwagon. Dr. Marchioni also names his favorite CBM stocks.
  • Why Swiss Medica's O24™ Works for Pain Relief
    Noted Herbalist Discusses the Active Mechanisms of Swiss Medica’s (OTC BB: SWME) O24™. Vertolli was a member of Health Canada’s advisory panel on natural health products (Canada’s equivalent of the U.S. Food and Drug Administration). He believes there are constituents within the O24™ Essential Oil pain relief product, which may act as powerful anti-inflammatory agents. Vertolli explained that the constituents within the O24™ pain relief product have undergone rigorous clinical testing.
  • James Dines Predicts a Buying Panic in Uranium
    Over the years, Dines successfully forecast the Internet mania, forecasting the giants of the tech boom, and forecasting the tech bust. A gold bug again, Dines also added uranium as the metal to watch over the coming years, saying, “This is my way of playing the whole coming energy boom." We talked with Jim Dines about the "melt up" in the uranium sector.
  • Why Is Eric Sprott A Uranium Bull?
    Eric Sprott may be Canada's answer to Warren Buffet. He's got the Midas Touch and currently manages more than $3 billion. We talked to Eric Sprott about uranium and why he is bullish on nuclear energy. His funds have been one of the leading investors in uranium stocks, riding the crest of a rocket ride upwards in the spot price of uranium.
  • Could Spot Uranium Prices Reach $100/pound?
    Energy Guru Bill Powers Forecasts Uranium Shortfall in Three Years. Bill
    Powers focuses on investment opportunities in the Canadian energy sector,
    mainly independent oil & gas companies and now uranium companies. We
    talked with him and he thinks uranium could reach $100/pound this decade.
  • Swiss Medica Aims For Success #2 with PMS Escape
    Since acquiring the O24/Sport product from insolvent German-based General Cosmetics, Swiss Medica (OTC BB: SWME) roared onto the radar screens of U.S. and Canadian pharmacy chains. Part two of their corporate strategy was the necessity of an encore product to avoid being called a “single product company.” Obtaining the North American licensing rights to PMS Escape overcame that hurdle.
  • Will the Chimigen™ Vaccine Stop Bird Flu, Anthrax and Hepatitis?
    Can the human body be tricked into defending itself from viral infections? We interviewed Dr. Rajan George, Adjunct Faculty of the University of Alberta’s Pharmacy and Pharmaceutical Sciences Department. Dr. George is also Vice President of Research and Development for the Division of Infection Diseases of ViRexx Medical Co. As part of the team of University of Alberta scientists, a therapeutic vaccine is now being developed which may inoculate against Hepatitis, Anthrax and Avian Flu H5N1.
  • Explosion in Nuclear Energy Demand Coming
    Sprott Asset Management uranium expert Kevin Bambrough talked with us about the “second leg” of the current uranium bull market. He sees a massive nuclear build up heading our way with “the environmentalists leading the charge.” He said many price projections may be inaccurate because “people are underestimating future demand.”
  • Which Uranium Companies Are Leveraged for Increased Nuclear Energy Demand?
    Summary: Sprott Asset Management uranium expert Kevin Bambrough talked with us about the “second leg” of the current uranium bull market. Bambrough names his favorite uranium companies, where he believes there is still room for growth. Bambrough believes industry insiders have underestimated the growth in demand for nuclear energy. He believes his favorite uranium stocks are still cheap and could be trading much higher in the future.
  • Speculators Could Drive Uranium to $55/Pound
    TradeTech LLC Chief Executive Gene Clark talked with StockInterview about the uranium bull market, where his price models show uranium prices heading and when to expect the peak of the current upward cycle of the bull market. When will “hard” times again hit the uranium market, and how long will the trough last? And what does the future hold for the uranium price? An industry insider gives us his insights.
  • How Did ISL Uranium Mining Begin?
    According to the World Nuclear Association, 21 percent of the world’s uranium production came about from ISL mining in 2004. We conducted interviews with some of the world’s top ISL experts, including the father of ISL, to help you better understand how uranium is currently mined for the world’s nuclear power plants.
  • How to Evaluate an ISL Uranium Company
    The key to in situ leach (ISL) mining is not necessarily its uranium pounds-in-the-ground. Key factors include permeability of the uranium orebody, size of the area covered by a deposit and the average grade of the ore body. We talked with leading geological and hydrology experts to help you better understand ISL mining to avoid getting misled.
  • Latest Technology Transfer Could Reduce Chinese Coal Mining Deaths
    More than 15 Chinese coal miners die every day, mainly from gas explosions released when new coal tunnels are opened. A revolutionary new drilling technology from Australia may help save Chinese coal miners’ lives and also help reduce air pollution by capturing the methane before it spreads into the atmosphere.
  • How is the Weekly Spot Uranium Price Calculated?
    Find out from the Ux Consulting president exactly how the spot price of uranium is calculated every week. It’s not so simple. It impacts uranium investors worldwide.
  • Foreign Demand May Jeopardize Uranium Supply for U.S. Utilities
    We discussed with Jeff Combs, the Ux Consulting president, from which countries future uranium supplies may come, and who is going after those supplies more aggressively. He warns about the risks and rewards of Kazakhstan and Mongolia, looks to Africa for supplies, and talks about Russia’s expansion.
  • Are There Any Great, New Mining Stocks Left?
    Where are the hot and cold spots around the world for resource investors? The stampeding bull market in commodities has investors reaching for new ideas. Highly respected newsletter writer Lawrence Roulston of “Resource Opportunities” favors Canada, Alaska and China for investing in mining and energy companies.
  • Could ViRexx Medical’s ‘Linked Recognition’ Research Lead to a Cancer Vaccine?
    Dr. Lorne Tyrrell pioneered lamivudine as the standard treatment for hepatitis B virus (HBV). Now a success, he observed the drug’s shortcomings. Now CEO of ViRexx Medical, Tyrrell hopes his latest development, Chimigen, will offer new hope for HBV, other infectious diseases, and cancer.
  • 9 Survival Tips for the Market Shakeout Blues
    Investors who bought during the top of the frothy commodities rally are now panicking or kicking themselves. Neither activity helps an investor or trader think straight. Below are a few tips in dealing with the current market shakeout
  • Will China’s New Five-Year Plan Force U.S. Utilities to Ration Your Electricity?
    Taking your electrical needs for granted? A new five-year plan announced by the Chinese government may put the reliability of your electrical supply at risk. China may snap up all the available uranium over the next few years. U.S. utilities depend upon uranium to power their nuclear reactors, which provide 20% of your electricity.
  • Inside A Company’s News Release
    Most investors read a company’s news releases, but don’t read between the lines to understand in which direction the company is heading. Hopefully, the guidance which follows may help you better understand what is really going with a company’s plans.
  • Getting Word of Mouth Started: New Book PR Method
    We wanted feedback and a greater audience before publishing the print version of our new book. We gambled on a ‘public and peer review’ to help improve the quality of our book, and at the same time get out word of mouth. Did it work?
  • Cohen Research Report Bullish on Pacific Asia China Energy
    We reviewed a research firm’s report on a coalbed methane company. Cohen Independent Research Group issued a Buy recommendation on the shares of Pacific Asia China Energy (TSX: PCE), calling those shares “grossly undervalued.” Why is it undervalued?

[1] [2] [3]

© 2007 Article Dashboard. All Rights Reserved.
Use of our service is protected by our Privacy Policy and Terms of Service

Powered by Article Dashboard